Lanean...
Update Breast Cancer 2019 Part 5 – Diagnostic and Therapeutic Challenges of New, Personalised Therapies in Patients with Advanced Breast Cancer
Significant advancements have been made in recent years in advanced breast cancer and nearly all of them have been in the field of targeted therapy. Pertuzumab and trastuzumab-emtansine (T-DM1) have been able to be introduced in HER2-positive breast cancer. Now other anti-HER2 therapies are being de...
Gorde:
| Argitaratua izan da: | Geburtshilfe Frauenheilkd |
|---|---|
| Egile Nagusiak: | , , , , , , , , , , , , , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Georg Thieme Verlag KG
2019
|
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6805215/ https://ncbi.nlm.nih.gov/pubmed/31656319 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1055/a-1001-9952 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|